Novo Nordisk Cuts Guidance as U.S. Challenges Intensify - WSJ
![Novo Nordisk receives FDA approval for Saxenda® (liraglutide [rDNA origin] injection) for chronic weight management](http://photos.prnewswire.com/prnfull/20141224/166096 "Novo Nordisk receives FDA approval for Saxenda® (liraglutide [rDNA origin] injection) for chronic weight management")
Novo Nordisk receives FDA approval for Saxenda® (liraglutide [rDNA origin] injection) for chronic weight management
Novo Nordisk targets Mexico for anti-obesity drug
A package of Victoza (Liraglutide) injectors, manufactured by Novo Nordisk, prescription pharmaceuticals photographed in a pharmacy Stock Photo - Alamy
A package of Victoza (Liraglutide) injectors, manufactured by Novo Nordisk, prescription pharmaceuticals photographed in a pharmacy Stock Photo - Alamy
Rx Item-Victoza Pen 0.6Mg 0.1 Inj 3 By Novo Nordisk Pharm
Diabetes Medicine Savings & Support | NovoCare®
A package of Victoza (Liraglutide) injectors, manufactured by Novo Nordisk, prescription pharmaceuticals photographed in a pharmacy Stock Photo - Alamy
Pharmaceutical Stocks Eye A Big New Market For Their Diabetes Drugs: Obesity | Investor's Business Daily
Novo Nordisk - Wikipedia
Rx Item-Victoza Pen 0.6Mg 0.1 Inj 2 By Novo Nordisk Pharm
Novo Nordisk's Saxenda keeps firm grip on obesity treatment market < Pharma < Article - KBR
Novo petitions FDA to require Victoza copies to go through clinical trials, pointing to complex manufacturing | Fierce Pharma
Savings & Support | NovoCare®
Liraglutide – Next-Generation Antidiabetic Medication - Clinical Trials Arena
![Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in the United States](https://photos.prnewswire.com/prnfull/20150421/200096 "Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in the United States")
Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in the United States
FDA Approves Novo Nordisk's Saxenda as a Treatment for Chronic Weight Management
Novo's Victoza has been approved in the EU - Nordic Life Science – the leading Nordic life science news service
